fluoxymesterone (Haloestin, Ora-Testryl)

From Aaushi
Jump to navigation Jump to search

Introduction

Tradenames: Haloestin, Ora-Testryl. DEA controlled substance. Class 3.

Indications

Dosage

  • hypogonadism 5-20 mg PO QD
  • inoperable breast cancer
    • 10-20 mg/day in divided doses
    • continue for 1 month for a subjective response
    • continue for 2-3 months for an objective response

Tabs: 2, 5, 10 mg.

Adverse effects

Drug interactions

Mechanism of action

androgen

More general terms

References

  1. The Pharmacological Basis of Therapeutics, 9th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1996
  2. Drug Information & Medication Formulary, Veterans Affairs, Central California Health Care System, 1st ed., Ravnan et al eds, 1998
  3. Kaiser Permanente Northern California Regional Drug Formulary, 1998
  4. Jump up to: 4.0 4.1 4.2 Deprecated Reference

Database